Advertisement

Cardiology

Home Cardiology
Early intravenous metoprolol before primary percutaneous coronary intervention does not reduce infarct size in a population with ST-segment elevation myocardial infarction

ACC: Pre-pPCI Metoprolol Doesn’t Reduce Infarct Size in STEMI

Metoprolol cut incidence of malignant arrhythmias; was not linked to increase in adverse events
Familial hypercholesterolemia mutations are seen in less than 2 percent of individuals with low-density lipoprotein cholesterol ≥190 mg/dL

ACC: Prevalence of Familial Hypercholesterolemia <2 Percent

For any given observed LDL cholesterol level, increased risk for CAD for FH mutation carriers
A community pharmacy-based intervention can reduce cardiovascular disease risk among high-risk patients

ACC: Pharmacist Intervention Can Cut Cardiovascular Risk

Twenty-one percent decrease in CVD risk after adjustment for baseline values, center effect
For patients with suspected coronary artery disease

ACC: Prognostic Value of Cardiac Noninvasive Tests Vary by Sex

Women seem to derive more prognostic value from computed tomographic angiography
Regular doses of vitamin D3 may improve cardiac function in heart failure patients

ACC: Vitamin D Found to Improve Cardiac Function in Heart Failure

Further studies necessary to determine whether this translates to improvements in outcomes
Intraarterial chemoradiotherapy (CRT) for head and neck cancer is tied to a higher incidence of cerebral infarction

Intraarterial Chemo + Radiation May Up Cerebral Infarctions

Findings from comparison with intravenous chemoradiotherapy
For patients with acute myocardial infarction

ACC: Losmapimod Doesn’t Cut Cardio Events After Acute MI

In part A of trial, no reduction in risk of composite of cardiovascular death, MI, severe recurrent ischemia
The "Paleo diet" may help older women lose weight

ENDO: ‘Paleo’ Diet May Benefit Heart Health Post Menopause

Trendy eating plan may cut cholesterol, disease risks in postmenopausal women
For intermediate-risk patients with severe aortic stenosis

ACC: TAVR Similar to Surgery for Intermediate-Risk Patients

Similar rate of any-cause death, disabling stroke for intermediate-risk patients with severe aortic stenosis
Ixmyelocel-T

ACC: Ixmyelocel-T Beneficial for Heart Failure With Reduced EF

Significant reduction in primary efficacy end point with ixmyelocel-T therapy